![Thomas Schuetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schuetz
Chief Executive Officer at
COMPASS THERAPEUTICS, INC.
Net worth: 14 M $ as of 2026-05-30
Profile
Thomas J.
Schuetz is the founder of Compass Therapeutics LLC, founded in 2014, serving as Manager.
Dr. Schuetz was the founder of Astellas Gene Therapies, Inc., founded in 2012, serving as Independent Director from 2013 to 2020.
Dr. Schuetz is the founder of Compass Therapeutics, Inc., founded in 2014, serving as Vice Chairman, President & CEO since 2024.
Current jobs include Director at Arteaus Therapeutics LLC and Director at GLyPharma Therapeutic, Inc. Former jobs include President, Chief Executive Officer & Director at Olivia Ventures, Inc.; Director at Enobia Pharma, Inc. from 2007 to 2012; Independent Director at Relypsa, Inc. from 2013 to 2016; Vice President-Clinical Affairs at Transkaryotic Therapies, Inc.; Venture Partner at OrbiMed Advisors LLC; Chief Medical Officer at Gelesis, Inc.; Advisor at Limulus Management Co. LLC; Chief Medical Officer at Therion Biologics Corp.
from 2003 to 2006; and Entrepreneur-in-Residence at OrbiMed Advisors Private Equity.
Education includes a doctorate from Harvard University, an undergraduate degree from Xavier University, and a doctorate from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 5,909,586 ( 3.28% ) | 14 M $ | 2026-05-30 |
Thomas Schuetz active positions
| Companies | Position | Start |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Chief Executive Officer | 2024-05-27 |
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology Develops oncology therapeutic treatment | Director/Board Member | - |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Corporate Officer/Principal | - |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Develops novel therapies for migraine prevention | Director/Board Member | - |
Former positions of Thomas Schuetz
| Companies | Position | End |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Founder | 2020-01-14 |
| RELYPSA INC | Director/Board Member | 2016-08-31 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Director/Board Member | 2011-12-31 |
Therion Biologics Corp.
 Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for cancer patients | Chief Tech/Sci/R&D Officer | 2005-12-31 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Schuetz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Arteaus Therapeutics LLC
Arteaus Therapeutics LLC BiotechnologyHealth Technology Develops novel therapies for migraine prevention | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xavier University
 Xavier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Finance |
Therion Biologics Corp.
Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for cancer patients | Health Technology |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology Develops oncology therapeutic treatment | Health Technology |
Olivia Ventures, Inc.
 Olivia Ventures, Inc. Financial ConglomeratesFinance Operates as blank check company | Finance |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
- Stock Market
- Insiders
- Thomas Schuetz
Choose MarketScreener 
